These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4599117)

  • 21. Microbiological relevance and clinical potential of ampicillin-cloxacillin synergism.
    Barrelet L; Regamey C; Waldvogel FA
    Biomedicine; 1977 May; 26(3):169-75. PubMed ID: 329905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance types in Enterobacter cloacae. Occurrence and resistance to Ampicillin, Carbenicillin, Cephalothin and Mecillinam. Transfer of ampicillin Resistance.
    Søgaard P
    Acta Pathol Microbiol Immunol Scand B; 1982 Jun; 90(3):229-33. PubMed ID: 6922669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Kinetics of the bactericidal effect of ampicillin, penicillin G, carbenicillin, cephalothin, kanamycin, gentamycin, polymyxin B and sulfamethoxazole-trimethoprim on Escherichia coli].
    Stille W; Shah P
    Arzneimittelforschung; 1973 Jan; 23(1):58-60. PubMed ID: 4353376
    [No Abstract]   [Full Text] [Related]  

  • 24. Ampicillin resistance of Shigella sonnei.
    Smith JT; Bremner DA; Datta N
    Antimicrob Agents Chemother; 1974 Oct; 6(4):418-21. PubMed ID: 4157337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of R-factor-mediated drug-metabolizing enzymes on survival of Escherichia coli K-12 in presence of ampicillin, chloramphenicol, or streptomycin.
    Lundbäck AK; Nordström K
    Antimicrob Agents Chemother; 1974 May; 5(5):492-9. PubMed ID: 4618459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of Escherichia coli to penicillins. 8. Physiology of a class II ampicillin-resistant mutant.
    Nordström K; Burman LG; Eriksson-Grennberg KG
    J Bacteriol; 1970 Mar; 101(3):659-68. PubMed ID: 4985589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escherichia coli resistant to ampicillin/sulbactam.
    Eng RH; Yen K; Smith SM; Citron DM; Goldstein EJ; Greenberg R; Cherubin CE
    Chemotherapy; 1992; 38(6):399-404. PubMed ID: 1288964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity against Escherichia coli of CGP 9000, a new oral cephalosporin.
    Greenwood D
    J Antibiot (Tokyo); 1978 Jul; 31(7):697-702. PubMed ID: 357363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escherichia coli K-12 mutants hyperproducing chromosomal beta-lactamase by gene repetitions.
    Normark S; Edlund T; Grundström T; Bergström S; Wolf-Watz H
    J Bacteriol; 1977 Dec; 132(3):912-22. PubMed ID: 336612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae.
    Mendelman PM; Chaffin DO; Stull TL; Rubens CE; Mack KD; Smith AL
    Antimicrob Agents Chemother; 1984 Aug; 26(2):235-44. PubMed ID: 6333208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behaviour of TEM-1 beta-lactamase as a resistance mechanism to ampicillin, mezlocillin and azlocillin in Escherichia coli.
    Livermore DM; Moosdeen F; Lindridge MA; Kho P; Williams JD
    J Antimicrob Chemother; 1986 Feb; 17(2):139-46. PubMed ID: 3516962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM; Gebicka K; Borowski J
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
    [No Abstract]   [Full Text] [Related]  

  • 33. Sensitivities of strains of enteropathogenic Escherichia coli to cephalexin and other antibiotics.
    Konforti N; Halperin E
    Am J Clin Pathol; 1975 Jul; 64(1):121-6. PubMed ID: 1098437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-lactamase patterns and betalactam/clavulanic acid resistance in Escherichia coli isolated from fecal samples from healthy volunteers.
    Gulay Z; Bicmen M; Amyes SG; Yulug N
    J Chemother; 2000 Jun; 12(3):208-15. PubMed ID: 10877515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus species.
    Barry AL; Hoeprich PD
    Antimicrob Agents Chemother; 1973 Sep; 4(3):354-60. PubMed ID: 4202343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme.
    Rasmussen BA; Keeney D; Yang Y; Bush K
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2078-85. PubMed ID: 7811022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates.
    Noguchi H; Kubo M; Kurashige S; Mitsuhashi S
    Antimicrob Agents Chemother; 1978 May; 13(5):745-52. PubMed ID: 248269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. R-factor mediated resistance to penicillins which does not involve a beta-lactamase.
    Curtis NA; Richmond MH; Stanisich V
    J Gen Microbiol; 1973 Nov; 79(1):163-6. PubMed ID: 4204236
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug resistance and distribution of R factors among Escherichia coli strains.
    Tanaka T; Kobayashi A; Ikemura K; Hashimoto H; Mitsuhashi S
    Jpn J Microbiol; 1974 Sep; 18(5):343-7. PubMed ID: 4613899
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro susceptibility of Yersinia kristensenii strains to beta-lactam antibiotics.
    Bejar V; Calvo C; Ramos Cormenzana A
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(2):169-77. PubMed ID: 3501272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.